BCM
KLRS

BML Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

BML Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,011
Closed -$77.4K – 30
2024
Q4 		$77.4K Sell
8,011
-18,210
-69% -$176K 0.05% 24
2024
Q3 		$488K Hold
26,221
– – 0.29% 23
2024
Q2 		$436K Buy
26,221
+17,505
+201% +$291K 0.31% 26
2024
Q1 		$151K Buy
+8,716
New +$151K 0.1% 30